Mumbai/Pune: Vidal Health, a wholly owned subsidiary of Health Tech company Bajaj Finserv Health , has partnered with Serum Institute of India (SII), the world’s largest vaccine manufacturer, to support national efforts in cervical cancer prevention and awareness.

Starting October 1, 2025 , Vidal Health’s platform will provide a first-of-its-kind, end-to-end digital and cashless HPV vaccination experience. The programme will cover appointment booking, consent, certification, dosage reminders, and adherence monitoring, eliminating paperwork and streamlining continuity of care.

It is indicated that the HPV vaccine will be available directly through Vidal Health’s digital platform, ensuring timely access with no intermediaries. Users will benefit from digital registration, cashle

See Full Page